perioperative strategies in high-risk and oligometastatic renal cell and urothelial cancers
Published 1 year ago • 38 plays • Length 3:31Download video MP4
Download video MP3
Similar videos
-
4:04
perioperative treatment strategies for high-risk bladder cancer
-
1:18
using radiotherapy to manage oligometastatic kidney cancer
-
1:13:04
urowebinar: developments in perioperative immunotherapy for bladder and kidney cancers
-
0:45
histo-genetic risk classification in renal cell carcinoma
-
2:50
the role of cytoreductive nephrectomy and metastasectomy in renal cell carcinoma
-
3:43
risk stratification for metastatic renal cell carcinoma
-
19:55
adjuvant sunitinib for high risk renal cell carcinoma: not ready for prime time
-
25:48
the uromigos definition of oligometastatic: uromigos live 2024
-
1:32
the risks of combining therapies in renal cell carcinoma and bladder cancer
-
9:57
oligometastatic renal cell carcinoma
-
5:16
potential new treatments in renal cell carcinoma
-
1:28:18
navigating evolving standards of care in rcc: novel targeted and immunotherapy options
-
7:16
adjuvant therapy in high-risk renal cell cancer
-
3:30
promising results for axitinib and pembrolizumab in advanced renal cell cancer
-
3:04
kidney cancer: minimizing toxicities and hassle in adjuvant therapy
-
3:04
evaluating the role of radiotherapy in primary and metastatic rcc
-
56:44
advances in peri operative therapy in bladder and kidney cancer - t. l. rose - 20220427
-
1:08:16
the uromigos: perioperative therapy in rcc
-
39:34
10.19.20 urology covid didactics - treating metastatic renal cell carcinoma